Modulight Biotherapeutics

📍 Boston, United States🗓 Founded 2022👥 24 employees💰 Last funded Aug 2025
Modulight Biotherapeutics is developing a transformative optogenetic platform that precisely targets pathological neural activity when and where it occurs to restore balance in the nervous system.
10
Total investors
1
Early stage
9
Mid stage
0
Late stage
2022
Founded
Investor geography4 countries
Israel
5
France
2
United States
2
Singapore
1
Investor activity2022–2025 · investors recorded per year
2022120259
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Modulight Biotherapeutics?
Modulight Biotherapeutics has 10 investors on record on gritt.io, including 1 early-stage backers, 9 mid-stage.
When did Modulight Biotherapeutics last raise funding?
The most recent investment in Modulight Biotherapeutics recorded on gritt.io was in August 2025.
When was Modulight Biotherapeutics founded?
Modulight Biotherapeutics was founded in 2022.
What industry is Modulight Biotherapeutics in?
Modulight Biotherapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Modulight Biotherapeutics based?
Modulight Biotherapeutics is headquartered in Boston, United States.